Primary coronary angioplasty in 9,434 patients during acute myocardial infarction: Predictors of major inhospital adverse events from 1996 to 2000 in Brazil

Arquivos Brasileiros de Cardiologia

Volumn 79, Issue 4, 2002, Pages 412-418

  Mattos, Luiz Alberto ^a   Sousa, Amanda G M R ^a   Pinto, Ibraim M F ^a   De Moura Campos Neto, Cantídio ^a   Labrunie, André ^a   Alves, Claudia Rodrigues ^a   Saad, Jamil ^a  

^a NONE   (Brazil)

Author keywords

Coronary angioplasty; Myocardial infarction; Stents

Indexed keywords

ARTICLE; BRAZIL; CLINICAL TRIAL; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; RECURRENT DISEASE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UTILIZATION REVIEW;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BRAZIL; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROGNOSIS; RECURRENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 0036780049     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0066-782X2002001300008     Document Type: Review

References (23)

1. White HD. Future of reperfusion therapy for acute myocardial infarction. Lancet 1999; 354: 695-7.
2. Mattos LA, Cano MN, Maldonado G, et al. Empregoda angioplastia coronária no infarto agudo do miocárdio sem o uso prévio de agentes trombolíticos: análise de 201 pacientes. Arq Bras Cardiol 1990; 55: 279-86.
3. Sousa AGMR, Mattos LA, Moura Campos Neto C, et al. Intervenções coronárias percutâneas para revascularização no Brasil em 1996e 1997, comparadas as do biênio 1992 e 1993: relatório do Registro CENIC (Central National de Intervenções Cardiovasculares). Arq Bras Cardiol 1998;70:423-30.
4. Weaver WD, Simes J, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infartion. JAMA 1997; 278: 2093-98.
5. Grines CL, Ellis SG, Jones M, et al. Primary coronary angioplasty vs. thrombolytic therapy for acute myocardial infarction: long term follow up of ten randomized trial. Circulation 1999; 1001: 1-499.
6. Mattos LA, Sousa AGMR, Moura Campos Neto C, Labrunie A, Alves CR, Saad J. Angioplastia coronana primana e implante de stents no infarto agudo do miocardio: análise comparativa dos resultados hospitalares no registro CENIC/ SBHCI. Arq Bras Cardiol 1999; 73: 475-9.
7. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1,5 million patients with myocardial infarction in the US from 1990 through 1999. J Am Coll Cardiol 2000; 36: 2056-63.
8. Zahn R, Schiele R, Schneider S, et al. Decreasing hospital mortality between 1994 and 1998 in patients with primary angioplasty but not in patients treated with intravenous thrombolysis. J Am Coll Cardiol 2000; 36: 2064-71.
9. Zahn R, Schiele R, Schneider S, et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients profiting most from primary angioplasty? J Am Coll Cardiol 2001 ; 37: 1827-35.
10. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I. N Engl J Med 1985; 312: 932-6.
11. Censo Brasileiro de 1990-2000, Institute Brasileiro de Geografia e Estatística, Rio de Janeiro (www.ibge.gov.br).
12. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 2001; 357: 1905-14.
13. Grines CL, Cox D, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999; 341: 1949-56.
14. Stone GW. The CADILLAC Study: In-hospital and 6-month results. TCT (Transcatheter Cardiovascular Therapeutics) 2000, Washington D.C., USA, October, 2000.
15. Brener SJ, Barr LA, Burchenal MD, et al. Randomized, placebo controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 1998; 98: 734-41.
16. Neumann FJ, Kastrati A, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade with abcximab on clinical and angiographic restenosis rate after the placement of coronary stems following acute myocardial infarction. J Am Coll Cardiol 2000; 35: 915-21.
17. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein inhibition with coronary stenting for acute myocardial infartion. N Engl J Med 2001; 344: 1895-03.
18. Van den Merkhof LFM, Zijlstra F, Olsson H, et al. Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty: results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) Pilot study. J Am Coll Cardiol 1999; 33: 1528-32.
19. Hermann HC, Molitemo DJ, Ohman M, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO 4 pilot) Trial. J Am Coll Cardiol 2000; 36: 1489-96.
20. Topol EJ, Molitemo DJ, Hermmann HC, et al. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med 2001 ; 344: 1888-94.
21. Stone GW, Brodie BR, Griffin JJ, et al. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000; 35: 605-11.
22. Stone GW, Grines CL, Browne KF, et al. Predictors of in-hospital and 6 months outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1995; 25: 370-7.
23. Canto JG, Every NR, Magid DJ, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. N Engl J Med 2000; 342: 1573-80.